Scientists have discovered the key features of immune B cells which make them successful at targeting tumours – including ...

Pancreatic cancer is notorious for being highly aggressive and difficult to treat. Survival rates for this disease have barely improved at all in the last four decades, with only five per cent of ...

From mapping the paths of cancer evolution, to the design and discovery of novel drugs - we are leading in innovative cancer informatics. Cancer is a complex, ever-changing set of diseases, and new ...

Researchers at The Institute of Cancer Research, London, have increased our understanding of how a cancer drug called a PARP inhibitor stops working in women with breast cancer that has spread. This ...

Radiotherapy can be used alongside hormone treatment, delaying the need for chemotherapy and therefore significantly protecting their quality of life for some patients with advanced prostate cancer, ...

Professor Zoran Rankovic is Director of the Centre for Protein Degradation. He applies his targeted protein degradation, medicinal chemistry, and drug discovery expertise gained over 25 years of ...

Image: a woman walks her dog. Regular leisure time physical activity may reduce the risk of breast cancer for women before menopause, according to new research funded by Breast Cancer Now. The ...

Employees from land developer Socius have donned their running shoes to raise money for The Institute of Cancer Research – as members of our 2024 London Marathon team. Socius’ Head of Engagement Liam ...

As a fit and healthy former firefighter, Harry Hall didn’t think there was anything to worry about when he developed a lump in his neck. But after his wife persuaded him to go to the doctors, tests ...

It's an exciting time for research into high-risk neuroblastoma. Over the past year, multiple trials testing new treatments showed promising results, and in 2024, new trials are expected to open to ...

It's an exciting time for research into high-risk neuroblastoma. Over the past year, multiple trials testing new treatments showed promising results, and in 2024, new trials are expected to open to ...